Gaudium IVF Rectifies Consolidated Equity Share Capital Reporting Error
Gaudium IVF and Women Health Ltd · Outcome · 13 Nov 2026, 6:35 am
Gaudium IVF Rectifies Consolidated Equity Share Capital Reporting Error Gaudium IVF and Women Health corrected a typographical error in its consolidated financial results for the quarter and half-year ended 30th Sep'26, updating paid-up equity share capital to ₹3,639.34 lakhs from ₹3,519.34 lakhs. The revision has no impact on EPS, profits, or other financial metrics. For Q2 ended 30th Sep'26, consolidated revenue from operations reached ₹3,741.11 lakhs with net profit at ₹941.31 lakhs (EPS of ₹1.29), while standalone revenue stood at ₹2,805.68 lakhs and net profit was ₹819.97 lakhs. Unutilised IPO proceeds totaled ₹3,988.04 lakhs.
Original exchange filing (PDF)
More announcements from Gaudium IVF and Women Health Ltd
- Gaudium IVF and Women Health Limited has informed the Exchange about audio recording of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half .... · 17 Nov 2026
- Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 15 Nov 2026
- Monitoring Agency Report for quarter ended September 30, 2026 · 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange regarding revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. · 13 Nov 2026
- Revised Code of Practices and Procedures for fair Disclosure of Unpubulished Price Sensitive Information Pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. · 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 13 Nov 2026
- Statement of Deviation(s) or variation(s) Under Regulation 32 for the quarter ended September 30, 2026. · 13 Nov 2026
- Press Release on the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2026 · 13 Nov 2026
